featured
Efficacy and Safety of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Gastroenterology & Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Gastroenterol Hepatol 2024 Jul 01;9(7)620-631, AG Miethke, A Moukarzel, G Porta, J Covarrubias Esquer, P Czubkowski, F Ordonez, A Mosca, AA Aqul, RH Squires, E Sokal, D D'Agostino, U Baumann, L D'Antiga, N Kasi, N Laborde, C Arikan, CH Lin, S Gilmour, N Mittal, FK Chiou, SP Horslen, WD Huber, T Jaecklin, T Nunes, A Lascau, L Longpre, DB Mogul, W Garner, P Vig, VF Hupertz, RP Gonzalez-Peralta, U Ekong, J Hartley, N Laverdure, N Ovchinsky, RJ ThompsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.